HERON THERAPEUTICS, INC. /DE/ (HRTX) Other Assets, Noncurrent USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Heron Therapeutics, Inc. /De/ quarterly Other Assets, Noncurrent history and growth rate from 2010 to 2024.
  • Heron Therapeutics, Inc. /De/ Other Assets, Noncurrent for the quarter ending March 31, 2024 was $7.88 M, a 44.2% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $7.88 M -$6.25 M -44.2% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $8.13 M -$7.58 M -48.3% Dec 31, 2023 10-Q 2024-05-07
Q3 2023 $8.37 M -$8.96 M -51.7% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $8.58 M -$8.95 M -51% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $14.1 M -$3.84 M -21.4% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $15.7 M -$2.01 M -11.3% Dec 31, 2022 10-K 2024-03-12
Q3 2022 $17.3 M +$17 M +4907% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $17.5 M +$17.2 M +4968% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $18 M +$17.6 M +5096% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $17.7 M +$17.4 M +5021% Dec 31, 2021 10-K 2023-03-29
Q3 2021 $346 K $0 0% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $346 K $0 0% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $346 K $0 0% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $346 K $0 0% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $346 K +$92 K +36.2% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $346 K +$92 K +36.2% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $346 K +$92 K +36.2% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $346 K +$92 K +36.2% Dec 31, 2019 10-K 2021-02-24
Q3 2019 $254 K +$1 K +0.4% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $254 K -$173 K -40.5% Jun 30, 2019 10-Q 2019-08-05
Q1 2019 $254 K -$62 K -19.6% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $254 K -$9 K -3.42% Dec 31, 2018 10-K 2020-03-02
Q3 2018 $253 K -$10 K -3.8% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 $427 K +$164 K +62.4% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 $316 K +$53 K +20.2% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $263 K $0 0% Dec 31, 2017 10-K 2019-02-22
Q3 2017 $263 K +$133 K +102% Sep 30, 2017 10-Q 2017-11-06
Q2 2017 $263 K +$133 K +102% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $263 K Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $263 K +$218 K +484% Dec 31, 2016 10-K 2018-02-27
Q3 2016 $130 K -$44 K -25.3% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 $130 K $0 0% Jun 30, 2016 10-Q 2016-08-08
Q4 2015 $45 K -$85 K -65.4% Dec 31, 2015 10-K 2017-02-23
Q3 2015 $174 K +$44 K +33.8% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 $130 K $0 0% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 $130 K $0 0% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 $130 K $0 0% Dec 31, 2014 10-K 2016-02-19
Q3 2014 $130 K -$23 K -15% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 $130 K -$18 K -12.2% Jun 30, 2014 10-Q 2014-08-04
Q1 2014 $130 K $0 0% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 $130 K $0 0% Dec 31, 2013 10-K 2015-03-13
Q3 2013 $153 K +$23 K +17.7% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $148 K +$18 K +13.8% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 $130 K $0 0% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 $130 K $0 0% Dec 31, 2012 10-K 2014-03-07
Q3 2012 $130 K $0 0% Sep 30, 2012 10-Q 2012-11-05
Q2 2012 $130 K +$102 K +364% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 $130 K Mar 31, 2012 10-Q 2012-05-10
Q4 2011 $130 K +$77 K +145% Dec 31, 2011 10-K 2013-03-01
Q3 2011 $130 K Sep 30, 2011 10-Q 2011-11-07
Q2 2011 $28 K Jun 30, 2011 10-Q 2011-08-08
Q4 2010 $53 K Dec 31, 2010 10-K 2012-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.